Brain Cell Protection

Quincy Bioscience is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to treat the diseases of aging. The company's products focus on alleviating the consequences of impaired calcium homeostasis - the imbalance of calcium ions commonly thought to be related to neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, as well as normal age-related memory loss. Quincy Bioscience is set apart by its cutting-edge applications of the calcium-binding protein apoaequorin, which is breaking new ground in protecting against neuronal degeneration.

Preventing the Loss of Memory

Quincy Bioscience is dedicated to brain health on several fronts. In addition to our pharmaceutical aspirations we have developed a novel dietary supplement using our patent-pending technology. Our first supplement, Prevagen®, is now available nationwide in health food stores and Rite-Aid Pharmacies. The only supplement from a jellyfish, Prevagen keeps brain cells alive longer.* Research shows a 28-55% reduction in cellular death when treated with the jellyfish calcium-binding protein. Human trials have also indicated improvements in memory. Prevagen was developed by Quincy Bioscience and is the first supplement to address aging through the restoration of calcium-binding proteins. For more information please visit our website at www.prevagen.com.

Neurodegeneration and Memory Loss

Quincy Bioscience looks to address the loss of memory, neurodegenerative diseases and overall brain health within the human brain through the restoration of calcium-binding proteins. Quincy Bioscience anticipates that the development of this protein-based technology will help normal age-related memory loss and bring promising therapeutics for neurological based diseases such as Alzheimer’s and Parkinson's.

Visit Prevagen.com